today announced the presentation of two posters highlighting promising preclinical data for pipeline candidates RLYB212 and RLYB332 at the 66 th American Society of Hematology (ASH) Annual Meeting ...

announces an oral presentation and three poster presentations at the American Society of Hematology (ASH) Annual Meeting, being held from December 7-10, 2024, in San Diego. “Our oral ...

Two posters presented at the 2024 American Society of Hematology meeting bolster evidence supporting the long-term clinical benefits of ruxolitinib for polycythemia vera and chronic graft-vs-host ...

announces an oral presentation and three poster presentations at the American Society of Hematology (ASH) Annual Meeting, being held from December 7-10, 2024, in San Diego. "Our oral presentation at ...

At the meeting, NeoGenomics will present a poster: Monday, December 9 at 6-8 p.m. PST This study explores the prognostic effects of neuronal-glial and immune microenvironment signatures in primary ...

A poster presentation, by principal investigator Jessica Treviño Jones, MD, breast medical oncologist at Mays Cancer Center and associate professor in the Division of Hematology and Oncology at ...

But a recently launched clinical trial led by Jasmine Zain, M.D., director of the T Cell Lymphoma Program and professor of hematology and hematopoietic stem cell transplantation, puts these CTL ...

Poster title: “Phase 1 Safety and Efficacy of Tuspetinib Plus Venetoclax Combination Therapy in Study Participants with Relapsed or Refractory Acute Myeloid Leukemia (AML) Support Exploration of ...

During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December ... treating relapsed/refractory multiple myeloma (RRMM), were unveiled (Poster Number: 1990) ...

The abstracts, presented at the 66 th American Society of Hematology (ASH ... to improve SCD treatment using aRBCX. The first poster presents data from U.S. insurance claims, examined in a ...

CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, today announced the successful close of ...